CA1052781A - Prostaglandin analog precursors - Google Patents

Prostaglandin analog precursors

Info

Publication number
CA1052781A
CA1052781A CA267,449A CA267449A CA1052781A CA 1052781 A CA1052781 A CA 1052781A CA 267449 A CA267449 A CA 267449A CA 1052781 A CA1052781 A CA 1052781A
Authority
CA
Canada
Prior art keywords
dimethyl
minutes
indanyl
phosphonate
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA267,449A
Other languages
French (fr)
Inventor
Thomas K. Schaaf
Hans-Jurgen E. Hess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Priority to CA267,449A priority Critical patent/CA1052781A/en
Application granted granted Critical
Publication of CA1052781A publication Critical patent/CA1052781A/en
Expired legal-status Critical Current

Links

Abstract

ABSTRACT OF THE DISCLOSURE
Dialkyl oxophosponates of the formula:
wherein A is cycloalkyl of from three to ten carbon atoms, 1-adamantyl, 2-norbornyl, 2-(1,2,3,4-tetrahydronaphthyl).
2-indanyl or substituted 2-indanyl, wherein the substituent is halo, trifluoromethyl, lower alkyl or lower alkoxy; and n is an integer from 0 to 5; and a process for the preparation thereof; which compounds are useful as intermediates for preparing 15-substituted-.omega.-pentanor-prostaglandins.

Description

5'~

:

This is a divisiona]L of Application Serial No.185,366, filed on November 8, 1973, issued as P~t~nt No.
. 1~033,7~7 on June 27, 1978.
Thi3 inven~ion rela~es to novel dialkyl oxapho~-S phonatqg and the prepar~ion thëreof. The compou~d~ o~ his . invention are useful as xeagents in the preparation o~ the `. novel lS-sub6tituted-~-penta~orprostaglandins disclosed in ~he parent P~tent No. 1,033,727.
In accordance with the present invention there i~
provided a process for preparing a compound o~ the ~ormula: :

A-~CH2) -~-CH2-~ /
., CH3 ........... II
wherein A is cycloalkyl of from ~hree to ten carbon atoms, l-adamantyl, 2-norbornyl, 2-(1,2,3,4-tetrahydronaphthyl), 2-indanyl ox substituted 2-indanyl, wherein~the substituent is 1 15 halo, trifluoromethyl, lower alkyl or lower alkoxy; n is an ,7, in~eger ~rom O to 5; which comp~ises reacting a Iower alkyl ~ ester of the formula: :
:: R
A-~CH2)n-~-O-lower alkyl ~ wherein A and n ar~ as defined above, with dimethyl methyl--l~ 2Q phosphonate.
~ Tha fQllowing Examples illustrate the i~vention .:~: and the manner in which it may be perfo~m~d. I~ these I

': Examples all temperatures are expressed in Centigrade, all , melting and boilin~ points are unc~rrected.
,~
~;

. .

.;

... . . . . ..... . : . , . .. , ~ . . . . .

~:, . :....... , . . , , . . ,.. ~.. . .,. . . ,: . , . . , ,~ .
,, ~ ~; . ,.,, .. ': ,., ~, .....

` -2~ ~5'~7~
~ EXAMPLE 1 . .
Dimethyl 2-oxo-2-(2-indanyl)ethylphosphonate A solution of 20.4 g. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran was cooled to -78 in a dry nitrogen atmosph~re. To the stirred phosphonate solu~ion was added 82.6 ml. of 2.25M _-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) ~ropwise over a period of 20 minu~es at such a rate that ~he reaction - temperature never rose above -65. After an additional 5 minutes sti~ring at -78, 14.0 g. (73.5 mmole) methyl indane-
2-carboxylate was added dropwise at a rate that kept the re-action temperature less than -70 (20 minutes). After 1.0 hour at -73 the reaction mixture was allowed to warm to ambient ~emperature, neutralized with 20 ml. acetic acid and ro~ary evaporated to a white gel. The gelatinous material was taken up in 50 ml. water, the aqueous phase extracted with 75 ml. portions o~ methylene chloride (4x), the combined organic extracts were backwashed (75 ml. H2O), dried (MgSO4), and concentrated (water aspirator) to a crude residue and distilled, b.p. 150-160 (0.1 mm) to give 17.0 g. (86.4%) : dimethyl 2-oxo-2-(2-indanyl)ekhylphosphonate.
The nmr spectrum (CDC13) of the distilled product exhibited a singlet at 7.15 ~ for the aromatic protons, a doublet at 3.76 ~ (J = 11 cps) for the OCH3, a singlet at '~ ~5 3.25 ~ for the ben7.ylic protons, a doublet at 3.18 ~ (J = 23 cps) for the PCH2, and a deformed triplet at 3.13 ~ (J = 2 cps) for the CHCO.
Additional Compound of the Formula . O, C~
(MeO)2~CH2~(cH2)n 30 A n b.p. nmr Data (p~m c)_(a) MeO ~ 0 240-243 (0.2 mm) 6.73(s), 3.84(s), 3.78(d), 3.22(d) G ~
1 ~1 160-162 (0.2 mm) 3.77(d), 3.06(d), 2.50(d) ,~ (a)distinct reso~ances.
'' , :

.

_3_ ~5~
; Additional Compound of the Formula (cont'd) : ~ n ~ nmr Data (E~m_~)(a) 1 209-212 (0.02 mm) 3.70(d), 2.93(d), 2.23(s) 2 195-200 (0.02 mm) 3.75(d), 3.08(d), 2.53(m) ~ <~
, 1 138-141 (0.3 mm) 3.78(d), 3.05~d) (a)distinct resonances.
~ X~MPLE 2 Dimeth~1 2-oxo-3-~2-indanyl)~ æ o~honate A ~olution of 20.4 gO ~164 mmoles) dimethyl methyl-: 10 phosphonate tAldrich) in 200 ml. dry tetrahydrofuran i9 cool-ed to -78 in a dry nitrogen atmosphere. ~o the ~tlrred phosphonate solution i~ added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a period of 20 minutes at su~h a rate that he reaction lS temperature never rises above -65~ After an additional 5 minute~ ~tirring at -78t 14.0 g. ~73O5 mmole) methyl ~2-indanyl)acetate is added dropwise at a rate that keep~ the reaction temperature les~ than -70 ~20 minutes). After 1.0 hour at -78 the reaction mixture i~ allowad to warm to amb~ent temperatur~, ~eutralized w~th ao ml. ac~tic acid and rotary evaporat~d to a white gel. The galatlnou~ matar~al i8 takon up in 50 ml~ wate~, the aque~us pha~e extracted with 75 ml~ por~lonR o~ methylene chlorida ~4x), ~he com~ined organic ~xtract~ ara backwa~had (75 ml~ H2O), drlad tMgSO4), a~d aonc~nt~ated ~water a~pirator) to a arud~ r~ldue and di~illed, d:Lmethyl 2-oxo~3~ indanyl)propylpho~phona~e.
The produa~ o~ thi~ Example i~ u~e~ul a~ th~ start- -lng material for ~h~ ~ynthesis o~ 16-(2-indanyl)-~-tetranor-prostagland~n~ o~ the A, E, or F series via the proc~dur~s di~closed in Patent No. 1,033,727. Othex pre~ursor~ required ~or th~ ~ynth~ of 17 ~hrough 20 ~ub~tituted pro~taglandln ~, . , ~ ~ . .

. . - ,, . , . :

. : . ; : : , . . .. . . .
.' ~ . ' . . ' ' .:' . .

sf~
; 4-analogs disclosed in Patent No. 1,033,727 are prepared in the same way from the appropriate methyl esters.

.
Dimethyl 2-oxo-2-t2-(1,2,3,4-tetrahydrona~hthy~))phosphonate ; 5 A solution of 20.4 g. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cool-ed to -78 in a dry nitrogen a~mosphere. To the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwi~e over a period of 20 minutes at such a rate that the reaction temperature never rises above -65. A~ter an additional 5 minutes stirring at -78, 14.0 g. (73.5 INmole) methyl 2-(1,2,3,4-tetrahydronaphthylcarboxylate) is added dropwise at a rate tha~ keeps the reaction temperature le s than 70 ; 15 (20 minutes). After 1.0 hour at -78 the reaction mixture is allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated to a whits gel. The gelatinous material is taken up in 50 ml. water, the aqueous ` phase extracted with 75 ml. portion~ of methylene chloride (4x), the combinad organic extracts are backwashed (75 ml.
- H2O), dried (MgSO4), and concentrated (water aspirator) to a crude residue and distilled to give dimethyl 2-oxo-2-(2-(1,2,3,4-tetrahydronaphthyl))ethylphosphonate.
The product of this Example is useful as the start-ing material for the synthesis of 15-(2-(1,2,3,4-tetrahydro-naphthyl))-~-tetranorprostaglandins of the A, E, or F series via ~he procedures disclosed in Patent No. 1,033,727. Other ~,; precursors required for the synthesis of 16 through 20 sub-stituted prostaglandin analogs disclosed in Patent NoO
1,033,727 are prepared in the same way from the appropriate ;- methyl esters.
EX~MPLE 4 Dimethyl 2-oxo-2-(2-~R-1,2,3,4-tetrahydronaphthyl))ethyl-hosnhonate `~ 35 A solution of 20~4 g. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cool-ed to -78 in a dry nitro~en atmosphere. To the stirred ;; : .
. ~ . . .

~S'~71~
.5 phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a period of 20 minutes at~ such a rate that the reaction temperature never rises above -65. After an additional 5 minutes stirring at -78, 14.0 g. (73.5 mmole) methyl 2-(R-1,2,3,4-tetrahydronaphthylcarboxylate) is added drop~ise at a rate that keeps the reaction temperature less than -70 (20 minutes). After 1.0 hour at -78 the reaction mixture is allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated ~o a white gel. The gelatinous material is taken up in 50 ml. waker, the aqueous phase extracted with 75 ml. portions of methylene chloride (4x), the combined organic extracts are backwashed (75 ml.
H2O), dried (MgSO4), and concentrated (water aspirator) to a crude residue which is purified by column chroma~ography to give dime~hyl 2-oxo-2-~2-(R-1,2,3,4-tetrahydronaphthyl)3-ethylphosphonate.
The product o~ this Example is useful a~ the start-ing material for the synthesis of 15-(2-(R-1,2,3,4-tetra-hydronaphthyl))-~-tetranorprostaglandins of the A, E, or F
series via the procedures disclosed in Pa~ent No. 1,033,727.
Other precursors required for the synthesis of L6 through 20 substituted prostaglandin analogs disclosed in Patent No.
1,033,727 are prepared in the same way from the appropriate methyl esters.
E~AMPLE 5 Dimethyl 2-oxo-2-(2-(S-1,2,3,4-tetrahydronaphthyl))ethyl-~hos~honate . ~ . . ~ .
A solution o~ 20.4 y. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cool-ed to -78 in a dry nitrogen atmosphere. ~o the stirred phosphonate solution is added 82.6 ml. of 2.25M _-butyllithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a perlod of 20 minutes at suoh a rate that the rQaction temper-ature never rises above -Ç5. After an additional 5 minutes ` stirring at -78, 14.0 g. (73.5 mmole) methyl 2-(S-1,2,3,4-~ tetrahydronaphthyl) is added dropwise at a rate that keeps ,. .
. :
.,,~

:.~ . ~ . , . . , . , ,. . : . ~

~::., ' , . . . , :
'','' ~ ` ' ' ' ' ' ;
:.: . . .
.

5'~7~

the reaction temperature less than -70~ (20 minutes). After 1.0 hour at -78 the reaction mix~ure is allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated to a white gel. The gelatinous material is taken up in 50 ml. water, the aqueous phase extracted with 75 ml. portions of methylene chloride (4x), the combine~ organic extracts are backwashed (75 ml. H2O), dried (MgSO4), and con-;; centrated (water aspirator) to a crude residue which is i purified by column chromatography to give dimethyl 2-oxo-2-` 10 (2-(S-1,2,3,4-tetrahydronaph~hyl))ethylphosphonate.
The product of this Example is useful as the start-ing material for the syn~hesis of 15-(2-(S-1,2,3,4-tetra-hydronaphthyl))-~-tetranorprostaglandins of the A, ~ or F
series vla the procedures disclosed in Pat~nt No. 1,033,727.
Other precursors required for the synthesis of 16 through ~0 ~ubstituted prostaglandin analogs disclosed in Patent No.
1,033,727 are prepared in the same way from the appropriate methyl esters.

; 20 Dimethyl 2-oxo-7-cyclopentylhept~lphosphonate A solution of 20.4 g (164 mmoles) dimethyl methyl~
phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cooled to -78 in a dry nitrogen atmosphere. ~o the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwiseover a period of 20 minutes at such a rate that the reaction ; temperature never rises above -65. After an additional 5 minutes stirring at -78, 14.5 g. (73.5 mmole) methyl 6-cyclo-pentylhexanoate is added dropwise at a rate that keeps the 30 reaction temperature less than -70 (20 minutes~. After 1.0 hour at -78 the reaction mixture i9 allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated to a white gel. The gelatinous material is taken up in 50 ml. water, the aqueous phase extracted with 75 ml. portion~ of methylene chloride (4x), the combined organia extracts are backwashed (75 ml. H2O), dried ~MgSO4), and con-centrated ~water aspirator) to a crude residue and di~tilled , '"

:~"" . ', . .: ' ' ' . '."' ' ' ~ . . . . . ..

,: , . . .
,'.'.'"' , ,; . ,'' ,. , .'. ,',", "'. . ', ~: , ,, ' _7~ 7~
to give dimethyl-2--oxo-7-cyclopentylheptylphosphona~e.
The product of this Example is useful as the start-ing material for the synthesis of 20-cyclopentyl-~Ltetranor-prostaglandins of the A, E, or F series via the procedures disclosed in Patent No. 1,033,727. Other precursors required , for the synthesis of 15 through 19 substituted prostaglandin analogs disclosed in Patent No. 1,033,727 are pxepared in the same way from the appropriate methyl esters.

Dimethyl 2-oxo-2-c~clodecy~eth~lphosphonate A solution of 20.4 g. (164 mmole~) dimethyl methyl-phosphonate ~Aldrich) in 200 ml. dry tetrahydro~uran is cool-ed to -78 in a dry nitrogen atmosphere. To the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a period of 20 minutes at such a rate that the reaction temperature never rises above -65. After an additional 5 minutes stirring at -78, 14.5 g. ~73.5 mmole) methyl cyclo-decane~arboxylate is added dropwise at a rate thak kept the r~action temperature leqs than -70 (20 minutes). After 1.0 , hour at -78 the reaction mixture is allowed to warm to ambient temperature, neutralized with 20 mlO acetic acid and rotary evaporated to a white gel. The gelatinous material is taken up in 50 ml. water, the aqueous pha~e extracted with 75 ml. portions of methylene chloride (4x), the combined organic , extracts are backwashed (75 ml. H2O), dried ~MgSO4), and con-`' centrated (water aspirator) to a crude residue and distilled to give dimethyl 2-oxo-2-cyclodecylethylpho~phonate.
The product of this Example is useful as the start-ing ma~erial for the synthesis of 15-cyclodecyl~-tetranor-prostaglandins of the A, E, or F series via the procedures disclosed in Patent No. 1,033,727. Other precursorq required for the synthe~is o~ 16 through 20 substikuted proskaglandin analogs disclosed in Patent No. 1,033,727 are prepared in the same way ~rom the appropriate methyl esters.

, , ~ . , .. ~ ,.
... . .

.

. . , : :
." ' ' ' ' :: ~ , s ~ . .

EX~MPLE 8 : Dimethyl 2-oxo-6-cyclopropylhexylpho~e_onate A solution o~ 20.4 g. (164 mmoles) dimethyl methyl-pho~phonate (~ldrich) in 200 ml. dry tetrahydro~uran is cool-S ed ~o -78 in a dry nitrogen atmosphere. To the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexan~ solution (Al~a Inorganics, Inc.) dropwiae over a period of 20 minute~ at such a rate that tha reaction ; tempera~ure never rises above -65. After an addltional 5 minu~es stirring at -78, 11.5 g. ~73.5 mmol~) methyl 5-cyclopropylvalerate i~ added dropwise at a rate that keep~
the react~on t~mperature le~s than -70~ (20 minutes)~ After 1.0 hour at -78 the reaction mixture i~ allowed to wa~m to a~bient temperature, neutralized with 20 ml. acetic acid and rotary evaporated ~o a white gel. The gelatinous material i8 taken up in 50 ml. water, the a~ueous phase extract~d with 75 ml. portion3 of methylene chlorid~ ~4x), thc combined organic extracts are backwashed (75 ml. H~O), dried ~MgSO4), and concentrated (water aspirator) to a crude re~ldue and distill~d to give dimethyl 2 oxo-6-cyclopropylhexylpho~phonate.
The product o~ this Example is uR~ful as the start-ing material for the synthesis of l9-cyclopropyl-~-tetranor-prostaglandins of the A, E or F erie~ via the procedures disclo~ed in Paten~ No. 1,033,727. Other precuxsor~ required for the synthesi3 o~ 15 thrsugh 18 and 20 ~ub3titute~ prosta-i glandin analogs disclo~ed in Patent Mo. 1,033,727 axa prepared in the same way from the appropriata methyl e~tex~.

.... :
~. 1 .~ .

;. ~ .

. . .

, . . . . , . , ... : ..
, . . . .

Claims (2)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. A process for preparing a compound of the formula:

...II
wherein A is cycloalkyl of from three to ten carbon atoms, 1-adamantyl, 2-norbornyl, 2-(1,2,3,4-tetrahydronaphthyl), 2-indanyl or substituted 2-indanyl, wherein the substituent is halo, trifluoromethyl, lower alkyl or lower alkoxy; n is an integer from 0 to 5; which comprises reacting a lower alkyl ester of the formula:

wherein A and n are as defined above, with dimethyl methyl-phosphonate.
2. A compound of the formula:

...II
wherein A and n are as defined in claim 1, when prepared by a process according to claim 1.
CA267,449A 1972-11-08 1976-12-08 Prostaglandin analog precursors Expired CA1052781A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA267,449A CA1052781A (en) 1972-11-08 1976-12-08 Prostaglandin analog precursors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08
CA267,449A CA1052781A (en) 1972-11-08 1976-12-08 Prostaglandin analog precursors

Publications (1)

Publication Number Publication Date
CA1052781A true CA1052781A (en) 1979-04-17

Family

ID=25668408

Family Applications (1)

Application Number Title Priority Date Filing Date
CA267,449A Expired CA1052781A (en) 1972-11-08 1976-12-08 Prostaglandin analog precursors

Country Status (1)

Country Link
CA (1) CA1052781A (en)

Similar Documents

Publication Publication Date Title
Trost et al. New synthetic reactions. Convenient approach to methyl 3-oxo-4-pentenoate
EP0841063A1 (en) Ketone derivatives and medicinal use thereof
IL50310A (en) Dimethyl ketophosphonates
Yuan et al. Enantioselective reduction of 2‐keto‐3‐haloalkane phosphonates by baker's yeast
Caldwell et al. Synthesis of the lipophilic side chain of the cyclic hexadepsipeptide antibiotic L-156,602
CA1052781A (en) Prostaglandin analog precursors
EP0585104B1 (en) A method of preparing a saturated monocyclic hydrocarbon compound and an intermediate therefor
US4323678A (en) Process for the manufacture of diazinon
US3910958A (en) Process for preparing arylacetic acids and esters thereof
CA1196000A (en) Process for production of methyl 2- tetradecylglycidate
SU1068033A3 (en) Process for preparing substituted trans-crysanthemates
CA1101874A (en) Thiophene compounds
Durden et al. Insecticidal thiophan-3-one O-(methylcarbamoyl) oximes
US3089896A (en) Preparation of enolates of
Mikołajczyk et al. α-Alkyl (aryl) sulfenyl substituted β-ketophosphonates: synthesis, properties and reactivity
JPH02292263A (en) Production of 1-methyl-3-alkyl-5-pyrazole carboxylate
JPH0257535B2 (en)
JPS5865249A (en) Manufacture of dichloroacetic acid ester
Knol et al. An alternative enantioselective synthesis of (+)-tricyclodecadienone
Gurskii et al. Organoboron compounds: CDXCV. A regioselective reaction of hydride abstraction in the series of 3-alkyl-3-borabicyclo [4.3. 1] decane ate-complexes
US4808340A (en) Process for preparing methyl 4-oxo-5-tetradecynoate
Petrova et al. Stereoselectivity of the Wittig-Horner reaction with benzylphosphonate carbanions and aldehydes
HU176072B (en) Process for producing 4-alpha-halogenomethyl-cyclopenta-square bracket-b-square bracket closed-furane derivatives
JPS6129351B2 (en)
HU182691B (en) Process for preparing 3-/2,2-dichloro-vinyl/-2,2-dimethyl-cyclopropane-carboxylic acid and esters thereof